Elite in Allergic Bronchopulmonary Aspergillosis

Ritesh K. Agarwal

DM Wayanad Institute Of Medical Sciences
Wayanad, KL, IN 
Elite in Allergic Bronchopulmonary Aspergillosis
DM Wayanad Institute Of Medical Sciences
Wayanad, KL, IN 
OverviewLocationsClinical Research

Overview

Ritesh Agarwal practices in Wayanad, India. Mr. Agarwal is rated as an Elite expert by MediFind in the treatment of Allergic Bronchopulmonary Aspergillosis. His top areas of expertise are Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Sarcoidosis, Endoscopy, and Lung Transplant.

His clinical research consists of co-authoring 611 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 115 articles in the study of Allergic Bronchopulmonary Aspergillosis.

Gender
Male

Locations

DM Wayanad Institute of Medical Sciences
Wayanad, KL, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Study Evaluating the Diagnostic Yield and Safety of the ProCore vs Conventional EBUS-TBNA Needle in Subjects With Suspected Sarcoidosis
A Study Evaluating the Diagnostic Yield and Safety of the ProCore vs Conventional EBUS-TBNA Needle in Subjects With Suspected Sarcoidosis
Enrollment Status: Completed
Publish Date: February 23, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Randomized-controlled Trial to Compare the Effectiveness of 4% Nebulized Lignocaine Versus 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy
A Randomized-controlled Trial to Compare the Effectiveness of 4% Nebulized Lignocaine Versus 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy
Enrollment Status: Completed
Publish Date: February 23, 2021
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Phase IIb Randomized, Double Blind, Two Arm, Controlled Clinical Trial of Mycobacterium W in Combination With Standard Therapy Versus Standard Therapy Alone in Sepsis
Phase IIb Randomized, Double Blind, Two Arm, Controlled Clinical Trial of Mycobacterium W in Combination With Standard Therapy Versus Standard Therapy Alone in Sepsis
Enrollment Status: Completed
Publish Date: February 23, 2021
Intervention Type: Biological, Other
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

611 Total Publications

Foreign body removal.
Foreign body removal.
Journal: Current opinion in pulmonary medicine
Published: October 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Agarwal's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 18 Advanced Conditions
View All 75 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile